New User? Sign Up | Sign In

Insider Trading - Keros Therapeutics Inc. (KROS)

Select Time period:

Enter Stock Symbol or Cik: Cik Lookup...

Search By Company or Insider Name:
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Email a friend >>...

SPAC List: List of Special Purpose Acquisition Companies

KROS Insider Trading Transactions for Keros Therapeutics Inc.

Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2020-04-13
Purchase
2020-04-13
5:12 pm
Keros Therapeutics Inc. KROS GORDON CARL L
Director
375,200 $16 $6,003,200 1,119,812
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:13 pm
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
437,499 $16 $6,999,984 149,262
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:15 pm
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
120,000 $16 $1,920,000 2,013,102
(Indirect
Direct)
View
2020-04-13
Purchase
2020-04-13
5:16 pm
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
437,499 $16 $6,999,984 149,262
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:17 pm
Keros Therapeutics Inc. KROS ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
375,200 $16 $6,003,200 1,119,812
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:18 pm
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
437,499 $16 $6,999,984 149,262
(Indirect)
View
2020-04-13
Purchase
2020-04-13
5:19 pm
Keros Therapeutics Inc. KROS Seehra Jasbir
CEO
20,000 $16 $320,000 243,856
(Direct)
View
2020-04-13
Purchase
2020-04-13
5:29 pm
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
120,000 $16 $1,920,000 2,013,102
(Direct)
View
2020-11-17
Purchase
2020-11-19
4:38 pm
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
60,000 $50 $3,000,000 155,262
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:39 pm
Keros Therapeutics Inc. KROS Kariv Tomer
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner
60,000 $50 $3,000,000 155,262
(Indirect)
View
2020-11-17
Purchase
2020-11-19
4:40 pm
Keros Therapeutics Inc. KROS Nussbaum Ran
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
Director
10% Owner
60,000 $50 $3,000,000 155,262
(Indirect)
View
2021-02-11
Sale
2021-02-16
5:47 pm
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
5,300 $64.91 $344,017 27,991
(Direct)
View
2021-02-11
Sale
2021-02-16
5:49 pm
Keros Therapeutics Inc. KROS Ordonez Claudia
Chief Medical Officer
1,000 $64.84 $64,841 0
(Direct)
View
2021-02-11
Sale
2021-02-16
5:50 pm
Keros Therapeutics Inc. KROS Knowles Julius
Director
19,029 $63.53 $1,208,936 450,930
(Indirect)
View
2021-02-16
Sale
2021-02-18
6:46 pm
Keros Therapeutics Inc. KROS Knowles Julius
Director
28,617 $60.87 $1,742,043 439,634
(Indirect)
View
2021-03-01
Sale
2021-03-03
8:40 pm
Keros Therapeutics Inc. KROS Knowles Julius
Director
23,690 $61.13 $1,448,078 430,283
(Indirect)
View
2021-03-03
Sale
2021-03-05
7:44 pm
Keros Therapeutics Inc. KROS Knowles Julius
Director
23,959 $56.45 $1,352,499 420,825
(Indirect)
View
2021-03-11
Sale
2021-03-15
4:43 pm
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
5,300 $64.48 $341,750 61,191
(Direct)
View
2021-03-11
Sale
2021-03-15
4:45 pm
Keros Therapeutics Inc. KROS Ordonez Claudia
Chief Medical Officer
1,000 $64.56 $64,556 0
(Direct)
View
2021-04-01
Sale
2021-04-05
9:11 pm
Keros Therapeutics Inc. KROS Knowles Julius
Director
38,353 $59.72 $2,290,536 405,685
(Indirect)
View
2021-04-06
Sale
2021-04-08
4:35 pm
Keros Therapeutics Inc. KROS Knowles Julius
Director
9,298 $58.81 $546,840 402,015
(Indirect)
View
2021-04-12
Sale
2021-04-14
4:43 pm
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
5,300 $60 $318,026 71,187
(Direct)
View
2021-04-12
Sale
2021-04-14
4:46 pm
Keros Therapeutics Inc. KROS Ordonez Claudia
Chief Medical Officer
1,000 $59.93 $59,926 0
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2020-04-07
Option Award
2020-04-08
9:00 pm
N/A
2030-04-06
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
241,222 $0 241,222
(Direct)
View
2020-04-07
Option Award
2020-04-08
9:01 pm
N/A
2030-04-06
Keros Therapeutics Inc. KROS Ordonez Claudia
Chief Medical Officer
18,430 $0 18,430
(Direct)
View
2020-04-07
Option Award
2020-04-08
9:02 pm
N/A
2030-04-06
Keros Therapeutics Inc. KROS Regnante Keith
CFO
18,430 $0 18,430
(Direct)
View
2020-04-07
Option Award
2020-04-08
9:02 pm
N/A
2030-04-06
Keros Therapeutics Inc. KROS Regnante Keith
CFO
133,622 $0 133,622
(Direct)
View
2020-04-07
Option Award
2020-04-08
9:03 pm
N/A
2030-04-06
Keros Therapeutics Inc. KROS Seehra Jasbir
CEO
696,569 $0 696,569
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:12 pm
N/A
N/A
Keros Therapeutics Inc. KROS GORDON CARL L
Director
744,612 $0 744,612
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:12 pm
N/A
N/A
Keros Therapeutics Inc. KROS GORDON CARL L
Director
148,922 $0 148,922
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:12 pm
N/A
N/A
Keros Therapeutics Inc. KROS GORDON CARL L
Director
744,612 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:12 pm
N/A
N/A
Keros Therapeutics Inc. KROS GORDON CARL L
Director
148,922 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
1,363,542 $0 1,734,395
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
663,825 $0 844,371
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
737,226 $0 937,735
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
169,307 $0 1,903,702
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
82,425 $0 926,796
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
91,538 $0 1,029,273
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
68,654 $0 68,654
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
163,612 $0 2,067,314
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
88,460 $0 1,015,256
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
79,653 $0 1,108,926
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
36,858 $0 105,512
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
1,363,542 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
663,825 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
737,226 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
169,307 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
82,425 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
91,538 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
68,654 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
163,612 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
88,460 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
79,653 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Kariv Tomer
Director
10% Owner
36,858 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
276,459 $0 414,688
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
184,305 $0 276,458
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
205,962 $0 620,650
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
137,308 $0 413,766
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
67,015 $0 687,665
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
44,676 $0 458,442
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
276,459 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
184,305 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
205,962 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
137,308 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
67,015 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:13 pm
N/A
N/A
Keros Therapeutics Inc. KROS Knowles Julius
Director
44,676 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:15 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
1,382,295 $0 1,382,295
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:15 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
343,270 $0 1,725,565
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:15 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
167,537 $0 1,893,102
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:15 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
1,382,295 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:15 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
343,270 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:15 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lazarus Alon
Director
10% Owner
167,537 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
1,363,542 $0 1,734,395
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
663,825 $0 844,371
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
737,226 $0 937,735
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
169,307 $0 1,903,702
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
82,425 $0 926,796
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
91,538 $0 1,029,273
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
68,654 $0 68,654
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
163,612 $0 2,067,314
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
88,460 $0 1,015,256
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
79,653 $0 1,108,926
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
36,858 $0 105,512
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
1,363,542 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
663,825 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
737,226 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
169,307 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
82,425 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
91,538 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
68,654 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
163,612 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
88,460 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
79,653 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:16 pm
N/A
N/A
Keros Therapeutics Inc. KROS Nussbaum Ran
Director
10% Owner
36,858 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:17 pm
N/A
N/A
Keros Therapeutics Inc. KROS ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
744,612 $0 744,612
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:17 pm
N/A
N/A
Keros Therapeutics Inc. KROS ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
148,922 $0 148,922
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:17 pm
N/A
N/A
Keros Therapeutics Inc. KROS ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
744,612 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:17 pm
N/A
N/A
Keros Therapeutics Inc. KROS ORBIMED ADVISORS LLC
OrbiMed Capital GP VII LLC
OrbiMed Genesis GP LLC
Director
148,922 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
1,363,542 $0 1,734,395
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
663,825 $0 844,371
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
737,226 $0 937,735
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
169,307 $0 1,903,702
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
82,425 $0 926,796
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
91,538 $0 1,029,273
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
68,654 $0 68,654
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
163,612 $0 2,067,314
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
88,460 $0 1,015,256
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
79,653 $0 1,108,926
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
36,858 $0 105,512
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
1,363,542 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
663,825 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
737,226 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
169,307 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
82,425 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
91,538 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
68,654 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
163,612 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
88,460 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
79,653 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:18 pm
N/A
N/A
Keros Therapeutics Inc. KROS Pontifax Management 4 G.P. (2015) Ltd.
Pontifax (Israel) IV L.P.
Pontifax (Cayman) IV L.P.
Pontifax (China) IV L.P.
Pontifax Late Stage Fund L.P.
Pontifax Late Stage GP Ltd.
10% Owner
36,858 $0 0
(Indirect)
View
2020-04-13
Conversion
2020-04-13
5:19 pm
N/A
N/A
Keros Therapeutics Inc. KROS Seehra Jasbir
CEO
11,169 $0 223,856
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:19 pm
N/A
N/A
Keros Therapeutics Inc. KROS Seehra Jasbir
CEO
11,169 $0 0
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:29 pm
N/A
N/A
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
1,382,295 $0 1,382,295
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:29 pm
N/A
N/A
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
343,270 $0 1,725,565
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:29 pm
N/A
N/A
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
167,537 $0 1,893,102
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:29 pm
N/A
N/A
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
1,382,295 $0 0
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:29 pm
N/A
N/A
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
343,270 $0 0
(Direct)
View
2020-04-13
Conversion
2020-04-13
5:29 pm
N/A
N/A
Keros Therapeutics Inc. KROS Arkin Bio Ventures Limited Partnership
Arkin Bio Venture Partners Ltd.
Arkin Moshe
10% Owner
167,537 $0 0
(Direct)
View
2020-05-29
Option Award
2020-05-29
5:19 pm
N/A
2030-05-29
Keros Therapeutics Inc. KROS Farzan Nima
Director
8,500 $0 8,500
(Direct)
View
2020-12-17
Option Award
2020-12-21
4:43 pm
N/A
2030-12-16
Keros Therapeutics Inc. KROS GRAY MARY ANN
Director
16,587 $0 16,587
(Direct)
View
2021-01-10
Option Award
2021-01-12
5:20 pm
N/A
2031-01-09
Keros Therapeutics Inc. KROS Seehra Jasbir
CEO
127,200 $0 127,200
(Direct)
View
2021-01-10
Option Award
2021-01-12
5:21 pm
N/A
2031-01-09
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
42,250 $0 42,250
(Direct)
View
2021-01-10
Option Award
2021-01-12
5:23 pm
N/A
2031-01-09
Keros Therapeutics Inc. KROS Ordonez Claudia
Chief Medical Officer
42,250 $0 42,250
(Direct)
View
2021-01-10
Option Award
2021-01-12
5:25 pm
N/A
2031-01-09
Keros Therapeutics Inc. KROS Regnante Keith
CFO
49,150 $0 49,150
(Direct)
View
2021-02-11
Exercise
2021-02-16
5:47 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
5,300 $0.3 33,291
(Direct)
View
2021-02-11
Exercise
2021-02-16
5:47 pm
N/A
2028-03-25
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
5,300 $0 145,605
(Direct)
View
2021-02-11
Exercise
2021-02-16
5:49 pm
N/A
N/A
Keros Therapeutics Inc. KROS Ordonez Claudia
Chief Medical Officer
1,000 $0.48 1,000
(Direct)
View
2021-02-11
Exercise
2021-02-16
5:49 pm
N/A
2029-09-18
Keros Therapeutics Inc. KROS Ordonez Claudia
Chief Medical Officer
1,000 $0 102,211
(Direct)
View
2021-02-26
Exercise
2021-03-01
4:54 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
33,200 $0.11 61,191
(Direct)
View
2021-02-26
Exercise
2021-03-01
4:54 pm
N/A
2027-02-05
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
33,200 $0 9,996
(Direct)
View
2021-03-11
Exercise
2021-03-15
4:43 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
5,300 $0.3 66,491
(Direct)
View
2021-03-11
Exercise
2021-03-15
4:43 pm
N/A
2028-03-25
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
5,300 $0 140,305
(Direct)
View
2021-03-11
Exercise
2021-03-15
4:45 pm
N/A
N/A
Keros Therapeutics Inc. KROS Ordonez Claudia
Chief Medical Officer
1,000 $0.48 1,000
(Direct)
View
2021-03-11
Exercise
2021-03-15
4:45 pm
N/A
2029-09-18
Keros Therapeutics Inc. KROS Ordonez Claudia
Chief Medical Officer
1,000 $0 101,211
(Direct)
View
2021-04-01
Exercise
2021-04-02
4:32 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
9,996 $0.11 71,187
(Direct)
View
2021-04-01
Exercise
2021-04-02
4:32 pm
N/A
2027-02-05
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
9,996 $0 0
(Direct)
View
2021-04-12
Exercise
2021-04-14
4:43 pm
N/A
N/A
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
5,300 $0.3 76,487
(Direct)
View
2021-04-12
Exercise
2021-04-14
4:43 pm
N/A
2028-03-25
Keros Therapeutics Inc. KROS Lachey Jennifer
Chief Scientific Officer
5,300 $0 135,005
(Direct)
View
2021-04-12
Exercise
2021-04-14
4:46 pm
N/A
N/A
Keros Therapeutics Inc. KROS Ordonez Claudia
Chief Medical Officer
1,000 $0.48 1,000
(Direct)
View
2021-04-12
Exercise
2021-04-14
4:46 pm
N/A
2029-09-18
Keros Therapeutics Inc. KROS Ordonez Claudia
Chief Medical Officer
1,000 $0 100,211
(Direct)
View